Literature DB >> 6372684

In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.

R L Hopfer, K Mills, R Mehta, G Lopez-Berestein, V Fainstein, R L Juliano.   

Abstract

The in vitro activities of liposome-encapsulated amphotericin B and free amphotericin B against Candida albicans 336 were comparable. Amphotericin B concentrations 12-fold and greater than 50-fold higher were required to kill the same organism when cholesterol and ergosterol were incorporated into the liposomes. The addition of cholesterol to liposomes caused a significant increase in the minimal fungicidal concentration of amphotericin B in 7 of 19 other yeast strains tested, whereas ergosterol caused an increase in 18 of the 19 strains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372684      PMCID: PMC185527          DOI: 10.1128/AAC.25.3.387

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B.

Authors:  G Lopez-Berestein; R Mehta; R L Hopfer; K Mills; L Kasi; K Mehta; V Fainstein; M Luna; E M Hersh; R Juliano
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

2.  Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes.

Authors:  R R New; M L Chance; S Heath
Journal:  J Antimicrob Chemother       Date:  1981-11       Impact factor: 5.790

3.  Freeze-fracture ultrastructural alterations induced by filipin, pimaricin, nystatin and amphotericin B in the plasmia membranes of Epidermophyton, Saccharomyces and red complex-induced membrane lesions.

Authors:  Y Kitajima; T Sekiya; Y Nozawa
Journal:  Biochim Biophys Acta       Date:  1976-12-02

4.  Amphotericin B in liposomes: a novel therapy for histoplasmosis.

Authors:  R L Taylor; D M Williams; P C Craven; J R Graybill; D J Drutz; W E Magee
Journal:  Am Rev Respir Dis       Date:  1982-05

5.  Effects of sterols on the therapeutic efficacy of liposomal amphotericin B in murine candidiasis.

Authors:  G Lopez-Berestein; R Mehta; R Hopfer; K Mehta; E M Hersh; R Juliano
Journal:  Cancer Drug Deliv       Date:  1983

6.  Treatment of murine cryptococcosis with liposome-associated amphotericin B.

Authors:  J R Graybill; P C Craven; R L Taylor; D M Williams; W E Magee
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

  6 in total
  22 in total

1.  Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.

Authors:  E D Ralph; A M Khazindar; K R Barber; C W Grant
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes.

Authors:  F Dromer; J Barbet; J Bolard; J Charreire; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

4.  Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF.

Authors:  R L Hopfer; R Mehta; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 5.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex.

Authors:  K Mitsutake; S Kohno; Y Miyazaki; T Noda; H Miyazaki; T Miyazaki; M Kaku; H Koga; K Hara
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

7.  Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.

Authors:  E M Johnson; J O Ojwang; A Szekely; T L Wallace; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.

Authors:  J Brajtburg; S Elberg; S J Travis; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 10.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.